ID   ELOV5_HUMAN             Reviewed;         299 AA.
AC   Q9NYP7; B4DZJ2; F6SH78; Q59EL3; Q5TGH5; Q6NXE7; Q7L2S5; Q8NCG4; Q9UI22;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   18-JUN-2025, entry version 186.
DE   RecName: Full=Very long chain fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE            EC=2.3.1.199 {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:10970790, ECO:0000269|PubMed:19575253, ECO:0000269|PubMed:20937905};
DE   AltName: Full=3-keto acyl-CoA synthase ELOVL5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=ELOVL fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE            Short=ELOVL FA elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Elongation of very long chain fatty acids protein 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Fatty acid elongase 1;
DE            Short=hELO1;
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
GN   Name=ELOVL5 {ECO:0000255|HAMAP-Rule:MF_03205}; Synonyms=ELOVL2;
GN   ORFNames=PRO0530;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10970790; DOI=10.1042/bj3500765;
RA   Leonard A.E., Bobik E.G., Dorado J., Kroeger P.E., Chuang L.-T.,
RA   Thurmond J.M., Parker-Barnes J.M., Das T., Huang Y.-S., Mukerji P.;
RT   "Cloning of a human cDNA encoding a novel enzyme involved in the elongation
RT   of long-chain polyunsaturated fatty acids.";
RL   Biochem. J. 350:765-770(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Suzuki T., Nitta A., Morita R., Sugimoto Y., Yamakawa K.;
RT   "Homo sapiens mRNA for elongation of very long chain fatty acids
RT   (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 (ELOVL2).";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Eye, Leiomyosarcoma, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 179-299 (ISOFORM 1).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 204-299 (ISOFORM 1).
RC   TISSUE=Liver;
RA   Zhang C., Yu Y., Zhang S., Ouyang S., Luo L., Wei H., Zhou G., Zhang Y.,
RA   Liu M., He F.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   CATALYTIC ACTIVITY.
RX   PubMed=19575253; DOI=10.1007/s11745-009-3320-8;
RA   Kitazawa H., Miyamoto Y., Shimamura K., Nagumo A., Tokita S.;
RT   "Development of a high-density assay for long-chain fatty acyl-CoA
RT   elongases.";
RL   Lipids 44:765-773(2009).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INVOLVEMENT IN SCA38, AND
RP   VARIANTS SCA38 VAL-72 AND VAL-230.
RX   PubMed=25065913; DOI=10.1016/j.ajhg.2014.07.001;
RA   Di Gregorio E., Borroni B., Giorgio E., Lacerenza D., Ferrero M.,
RA   Lo Buono N., Ragusa N., Mancini C., Gaussen M., Calcia A., Mitro N.,
RA   Hoxha E., Mura I., Coviello D.A., Moon Y.A., Tesson C., Vaula G.,
RA   Couarch P., Orsi L., Duregon E., Papotti M.G., Deleuze J.F., Imbert J.,
RA   Costanzi C., Padovani A., Giunti P., Maillet-Vioud M., Durr A., Brice A.,
RA   Tempia F., Funaro A., Boccone L., Caruso D., Stevanin G., Brusco A.;
RT   "ELOVL5 mutations cause spinocerebellar ataxia 38.";
RL   Am. J. Hum. Genet. 95:209-217(2014).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   INTERACTION WITH TECR.
RX   PubMed=38422897; DOI=10.1016/j.bbrc.2024.149588;
RA   Zhou Y., Lv R., Ye R.D., Ren R., Yu L.;
RT   "The 3-hydroxyacyl-CoA dehydratase 1/2 form complex with trans-2-enoyl-CoA
RT   reductase involved in substrates transfer in very long chain fatty acid
RT   elongation.";
RL   Biochem. Biophys. Res. Commun. 704:149588-149588(2024).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the four
CC       reactions that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process allows the addition
CC       of 2 carbons to the chain of long- and very long-chain fatty acids
CC       (VLCFAs) per cycle. Condensing enzyme that acts specifically toward
CC       polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6)
CC       acyl-CoA. May participate in the production of monounsaturated and of
CC       polyunsaturated VLCFAs of different chain lengths that are involved in
CC       multiple biological processes as precursors of membrane lipids and
CC       lipid mediators (By similarity) (PubMed:10970790, PubMed:20937905). In
CC       conditions where the essential linoleic and alpha linoleic fatty acids
CC       are lacking it is also involved in the synthesis of Mead acid from
CC       oleic acid (By similarity). {ECO:0000250|UniProtKB:Q8BHI7,
CC       ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:10970790,
CC       ECO:0000269|PubMed:20937905}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a very-long-chain acyl-CoA + malonyl-CoA + H(+) = a very-long-
CC         chain 3-oxoacyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:32727,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:90725, ChEBI:CHEBI:90736;
CC         EC=2.3.1.199; Evidence={ECO:0000255|HAMAP-Rule:MF_03205,
CC         ECO:0000269|PubMed:10970790, ECO:0000269|PubMed:19575253,
CC         ECO:0000269|PubMed:20937905};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32728;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z)-octadecatrienoyl-CoA + malonyl-CoA + H(+) =
CC         (8Z,11Z,14Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:35379, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57363, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:71481; Evidence={ECO:0000269|PubMed:10970790,
CC         ECO:0000269|PubMed:20937905};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35380;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoyl-CoA + malonyl-CoA + H(+) =
CC         (11Z,14Z,17Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36523, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:74034,
CC         ChEBI:CHEBI:74054; Evidence={ECO:0000269|PubMed:10970790,
CC         ECO:0000269|PubMed:20937905};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36524;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + malonyl-CoA + H(+) = 3-oxo-(11Z)-
CC         octadecenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:39675,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:61540, ChEBI:CHEBI:76555;
CC         Evidence={ECO:0000269|PubMed:10970790};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39676;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + malonyl-CoA + H(+) = 3-oxo-(11Z)-
CC         eicosenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36511, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:74011;
CC         Evidence={ECO:0000269|PubMed:10970790};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36512;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z)-octadecenoyl-CoA + malonyl-CoA + H(+) = 3-oxo-(13Z)-
CC         eicosenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:39679, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:75121, ChEBI:CHEBI:76559;
CC         Evidence={ECO:0000269|PubMed:10970790};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39680;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + malonyl-CoA + H(+) = (11Z,14Z)-
CC         3-oxoicosa-11,14-dienoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36503,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:57384, ChEBI:CHEBI:74012;
CC         Evidence={ECO:0000269|PubMed:20937905};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36504;
CC         Evidence={ECO:0000305|PubMed:20937905};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z,15Z)-octadecatetraenoyl-CoA + malonyl-CoA + H(+) =
CC         (8Z,11Z,14Z,17Z)-3-oxoicosatetraenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:35391, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:71489,
CC         ChEBI:CHEBI:71491; Evidence={ECO:0000269|PubMed:10970790};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35392;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + malonyl-CoA + H(+) =
CC         (7Z,10Z,13Z,16Z)-3-oxodocosatetraenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36475, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:73852; Evidence={ECO:0000269|PubMed:10970790,
CC         ECO:0000269|PubMed:19575253, ECO:0000269|PubMed:20937905};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36476;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl-CoA + malonyl-CoA + H(+)
CC         = 3-oxo-(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36483, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:73862,
CC         ChEBI:CHEBI:73863; Evidence={ECO:0000269|PubMed:10970790};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36484;
CC         Evidence={ECO:0000305|PubMed:10970790};
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:20937905}.
CC   -!- SUBUNIT: Interacts with TECR. {ECO:0000269|PubMed:38422897}.
CC   -!- INTERACTION:
CC       Q9NYP7; O14523: C2CD2L; NbExp=3; IntAct=EBI-11037623, EBI-12822627;
CC       Q9NYP7; O14653: GOSR2; NbExp=3; IntAct=EBI-11037623, EBI-4401517;
CC       Q9NYP7; P09601: HMOX1; NbExp=3; IntAct=EBI-11037623, EBI-2806151;
CC       Q9NYP7; P30519: HMOX2; NbExp=3; IntAct=EBI-11037623, EBI-712096;
CC       Q9NYP7; P24593: IGFBP5; NbExp=3; IntAct=EBI-11037623, EBI-720480;
CC       Q9NYP7; Q9NZG7: NINJ2; NbExp=3; IntAct=EBI-11037623, EBI-10317425;
CC       Q9NYP7; Q04941: PLP2; NbExp=3; IntAct=EBI-11037623, EBI-608347;
CC       Q9NYP7; Q9NUM3: SLC39A9; NbExp=3; IntAct=EBI-11037623, EBI-2823239;
CC       Q9NYP7; O15400: STX7; NbExp=3; IntAct=EBI-11037623, EBI-3221827;
CC       Q9NYP7; P57105: SYNJ2BP; NbExp=3; IntAct=EBI-11037623, EBI-1049004;
CC       Q9NYP7; Q8N2H4: SYS1; NbExp=3; IntAct=EBI-11037623, EBI-13075176;
CC       Q9NYP7; Q9UPZ6: THSD7A; NbExp=3; IntAct=EBI-11037623, EBI-310962;
CC       Q9NYP7; Q9BU79: TMEM243; NbExp=3; IntAct=EBI-11037623, EBI-12887458;
CC       Q9NYP7; A0AVG3: TSNARE1; NbExp=3; IntAct=EBI-11037623, EBI-12003468;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:20937905}; Multi-
CC       pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03205}. Cell
CC       projection, dendrite {ECO:0000255|HAMAP-Rule:MF_03205,
CC       ECO:0000269|PubMed:25065913}. Note=In Purkinje cells, the protein
CC       localizes to the soma and proximal portion of the dendritic tree.
CC       {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:25065913}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NYP7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYP7-2; Sequence=VSP_045918;
CC       Name=3;
CC         IsoId=Q9NYP7-3; Sequence=VSP_045917, VSP_045919;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in the adrenal gland
CC       and testis. Weakly expressed in prostate, lung and brain. Expressed in
CC       the cerebellum. {ECO:0000269|PubMed:10970790,
CC       ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:25065913}.
CC   -!- DISEASE: Spinocerebellar ataxia 38 (SCA38) [MIM:615957]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive incoordination
CC       of gait and often poor coordination of hands, speech and eye movements,
CC       due to degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCA38 is an autosomal dominant form
CC       characterized by adult-onset of slowly progressive gait ataxia
CC       accompanied by nystagmus. Brain MRI shows cerebellar atrophy.
CC       {ECO:0000269|PubMed:25065913}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL5 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03205}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF16688.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC11178.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF231981; AAF70631.1; -; mRNA.
DR   EMBL; AF338241; AAM00193.1; -; mRNA.
DR   EMBL; AL136939; CAB66873.1; -; mRNA.
DR   EMBL; AK074889; BAC11270.1; -; mRNA.
DR   EMBL; AK302948; BAG64104.1; -; mRNA.
DR   EMBL; AB209798; BAD93035.1; -; mRNA.
DR   EMBL; AL034374; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04419.1; -; Genomic_DNA.
DR   EMBL; BC017270; AAH17270.2; -; mRNA.
DR   EMBL; BC067123; AAH67123.2; -; mRNA.
DR   EMBL; BC074503; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074748; BAC11178.1; ALT_INIT; mRNA.
DR   EMBL; AF111849; AAF16688.1; ALT_INIT; mRNA.
DR   CCDS; CCDS4951.1; -. [Q9NYP7-1]
DR   CCDS; CCDS56433.1; -. [Q9NYP7-2]
DR   CCDS; CCDS56434.1; -. [Q9NYP7-3]
DR   RefSeq; NP_001229757.1; NM_001242828.2. [Q9NYP7-2]
DR   RefSeq; NP_001229759.1; NM_001242830.1.
DR   RefSeq; NP_001229760.1; NM_001242831.2. [Q9NYP7-3]
DR   RefSeq; NP_001288785.1; NM_001301856.2. [Q9NYP7-1]
DR   RefSeq; NP_068586.1; NM_021814.5. [Q9NYP7-1]
DR   AlphaFoldDB; Q9NYP7; -.
DR   SMR; Q9NYP7; -.
DR   BioGRID; 121914; 370.
DR   FunCoup; Q9NYP7; 714.
DR   IntAct; Q9NYP7; 41.
DR   MINT; Q9NYP7; -.
DR   STRING; 9606.ENSP00000359956; -.
DR   BindingDB; Q9NYP7; -.
DR   ChEMBL; CHEMBL5937; -.
DR   DrugBank; DB00132; alpha-Linolenic acid.
DR   DrugBank; DB11358; Evening primrose oil.
DR   SwissLipids; SLP:000000253; -.
DR   TCDB; 8.A.221.1.1; the very long chain fatty acid elongase (vlcfa-e) family.
DR   GlyGen; Q9NYP7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NYP7; -.
DR   PhosphoSitePlus; Q9NYP7; -.
DR   SwissPalm; Q9NYP7; -.
DR   BioMuta; ELOVL5; -.
DR   DMDM; 74753072; -.
DR   jPOST; Q9NYP7; -.
DR   MassIVE; Q9NYP7; -.
DR   PaxDb; 9606-ENSP00000359956; -.
DR   PeptideAtlas; Q9NYP7; -.
DR   ProteomicsDB; 27928; -.
DR   ProteomicsDB; 65118; -.
DR   ProteomicsDB; 83259; -. [Q9NYP7-1]
DR   Pumba; Q9NYP7; -.
DR   Antibodypedia; 4471; 358 antibodies from 28 providers.
DR   DNASU; 60481; -.
DR   Ensembl; ENST00000304434.11; ENSP00000306640.6; ENSG00000012660.14. [Q9NYP7-1]
DR   Ensembl; ENST00000370913.5; ENSP00000359951.5; ENSG00000012660.14. [Q9NYP7-3]
DR   Ensembl; ENST00000370918.8; ENSP00000359956.5; ENSG00000012660.14. [Q9NYP7-2]
DR   GeneID; 60481; -.
DR   KEGG; hsa:60481; -.
DR   MANE-Select; ENST00000304434.11; ENSP00000306640.6; NM_021814.5; NP_068586.1.
DR   UCSC; uc003pbr.3; human. [Q9NYP7-1]
DR   AGR; HGNC:21308; -.
DR   CTD; 60481; -.
DR   DisGeNET; 60481; -.
DR   GeneCards; ELOVL5; -.
DR   GeneReviews; ELOVL5; -.
DR   HGNC; HGNC:21308; ELOVL5.
DR   HPA; ENSG00000012660; Low tissue specificity.
DR   MalaCards; ELOVL5; -.
DR   MIM; 611805; gene.
DR   MIM; 615957; phenotype.
DR   OpenTargets; ENSG00000012660; -.
DR   Orphanet; 423296; Spinocerebellar ataxia type 38.
DR   VEuPathDB; HostDB:ENSG00000012660; -.
DR   eggNOG; KOG3071; Eukaryota.
DR   GeneTree; ENSGT01050000244838; -.
DR   HOGENOM; CLU_048483_0_1_1; -.
DR   InParanoid; Q9NYP7; -.
DR   OMA; CRFPMGW; -.
DR   OrthoDB; 434092at2759; -.
DR   PAN-GO; Q9NYP7; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NYP7; -.
DR   BioCyc; MetaCyc:ENSG00000012660-MONOMER; -.
DR   PathwayCommons; Q9NYP7; -.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   Reactome; R-HSA-9841922; MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis.
DR   SignaLink; Q9NYP7; -.
DR   SIGNOR; Q9NYP7; -.
DR   UniPathway; UPA00658; -.
DR   BioGRID-ORCS; 60481; 16 hits in 1156 CRISPR screens.
DR   ChiTaRS; ELOVL5; human.
DR   GeneWiki; ELOVL5; -.
DR   GenomeRNAi; 60481; -.
DR   Pharos; Q9NYP7; Tbio.
DR   PRO; PR:Q9NYP7; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9NYP7; protein.
DR   Bgee; ENSG00000012660; Expressed in seminal vesicle and 209 other cell types or tissues.
DR   ExpressionAtlas; Q9NYP7; baseline and differential.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0097447; C:dendritic tree; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; IBA:GO_Central.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_03205; VLCF_elongase_5; 1.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033677; ELOVL5.
DR   PANTHER; PTHR11157:SF18; ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 5; 1.
DR   PANTHER; PTHR11157; FATTY ACID ACYL TRANSFERASE-RELATED; 1.
DR   Pfam; PF01151; ELO; 1.
DR   neXtProt; NX_Q9NYP7; -.
DR   PharmGKB; PA128394703; -.
DR   TreeFam; TF323454; -.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Disease variant;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Neurodegeneration;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Spinocerebellar ataxia; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..299
FT                   /note="Very long chain fatty acid elongase 5"
FT                   /id="PRO_0000282838"
FT   TRANSMEM        26..46
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        64..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        112..132
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        139..158
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        168..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        205..225
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        226..246
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   REGION          274..299
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..288
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:25944712"
FT   MOD_RES         285
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         20..88
FT                   /note="DTRVKGWFLLDNYIPTFICSVIYLLIVWLGPKYMRNKQPFSCRGILVVYNLG
FT                   LTLLSLYMFCELVTGVW -> GISSSVLRMGPPLHTVVGWLQQLQAAHSEEEEKMFHLC
FT                   GFKHKEVVSQSSLPAVIPQNSLATIASHAPA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045917"
FT   VAR_SEQ         82
FT                   /note="E -> ESKREQPRRSACASRTDPSTQQQLPENR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045918"
FT   VAR_SEQ         89..299
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045919"
FT   VARIANT         72
FT                   /note="L -> V (in SCA38; dbSNP:rs587777671)"
FT                   /evidence="ECO:0000269|PubMed:25065913"
FT                   /id="VAR_072361"
FT   VARIANT         230
FT                   /note="G -> V (in SCA38; dbSNP:rs587777670)"
FT                   /evidence="ECO:0000269|PubMed:25065913"
FT                   /id="VAR_072362"
FT   CONFLICT        59
FT                   /note="F -> L (in Ref. 4; BAG64104)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167..262
FT                   /note="YFGATLNSFIHVLMYSYYGLSSVPSMRPYLWWKKYITQGQLLQFVLTIIQTS
FT                   CGVIWPCTFPLGWLYFQIGYMISLIALFTNFYIQTYNKKGASRR -> SVCADNHPDQL
FT                   RGHLAVHIPSWLVVFPDWIHDFPDCSLHKLLHSDLQQERGLPKERPPEGPPEWVHGCCE
FT                   WTHQQLFTPGKQCEAKEAAEGLKSKN (in Ref. 4; BAD93035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204..206
FT                   /note="QGQ -> EFH (in Ref. 9; BAC11178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="F -> S (in Ref. 9; BAC11178)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   299 AA;  35293 MW;  AE5150AA3432E984 CRC64;
     MEHFDASLST YFKALLGPRD TRVKGWFLLD NYIPTFICSV IYLLIVWLGP KYMRNKQPFS
     CRGILVVYNL GLTLLSLYMF CELVTGVWEG KYNFFCQGTR TAGESDMKII RVLWWYYFSK
     LIEFMDTFFF ILRKNNHQIT VLHVYHHASM LNIWWFVMNW VPCGHSYFGA TLNSFIHVLM
     YSYYGLSSVP SMRPYLWWKK YITQGQLLQF VLTIIQTSCG VIWPCTFPLG WLYFQIGYMI
     SLIALFTNFY IQTYNKKGAS RRKDHLKDHQ NGSMAAVNGH TNSFSPLENN VKPRKLRKD
//
